caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1124282983

Elvia CansecoM.D

PRACTICEELVIA CANSECO MD PLLCSee all providers at this practice →
OphthalmologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Elvia Canseco's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
3869
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
3170
Laboratory Corporation Of America
Clinical Laboratory · Houston, TX
2332
Christopher Fuller
Ophthalmology · Lubbock, TX
1518
MEMORIAL HERMANN HEALTH SYSTEM1117
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
45
Unique beneficiaries
—
Total services
60
Distinct HCPCS
3
Medicare payment
$3K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,238 Ophthalmology providers in TX — bottom quintile (cohort median 1,864).
PRESCRIBING · PART D · 2024
Total Rx claims
1,378
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
13
Brand share
64.3%
Top prescribed drugs
Lotilaner502 claims
Prednisolone Acetate223 claims
Moxifloxacin Hcl175 claims
Ketorolac Tromethamine139 claims
Bimatoprost97 claims
QUALITY · MIPS · 2024
Final MIPS score
89.8
Quality
81.5
Cost
76.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.62%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$116K
Payment records
158
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$80K
Consulting Fee$20K
Travel and Lodging$11K
Food and Beverage$6K